drugset / Trial / NCT01753310

Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.

NCT01753310

Phase 3 Completed 134 enrolled Ipsen
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the protocol is to evaluate the efficacy and safety of Dysport® using 2 mL dilution compared with placebo for the treatment of Cervical Dystonia.

Timeline

Start
2013-01
Primary completion
2014-10
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 250 iu Intramuscular
Comparator Botulinum toxin type A Protein / enzyme biologic 500 iu Intramuscular

Indications